ADAR and inflammatory bowel disease: An overall decrease in edited dsRNA levels may result in a higher risk of diseases, such as inflammatory bowel disease (IBD), coronary artery disease (CAD), diabetes, and Parkinson’s disease (PD).244 ADAR1, for example, is essential in regulating the inflammatory response.